2.5.3. Assessment of the risk of bias in the included studies
This protocol is extracted from research article:
Efficacy and safety of mechanical thrombectomy for cardioembolic stroke
Medicine (Baltimore), Jan 15, 2021; DOI: 10.1097/MD.0000000000024340

To assess the risk of bias for all included studies, Cochrane Collaboration's bias risk tool will be used by 2 independent review authors (ZZ and CW) to assess the following areas: random sequence generation, allocation concealment, blindness to participants, people, and results, incomplete outcome data, optional reporting, and other biases. Any discrepancies in the deviation risk assessment will be resolved through discussion. Ultimately, the quality of the studies will be divided into 3 levels: low risk of bias, high risk of bias, and unclear risk of bias. Disagreements will be resolved by discussion by arbiter (WX).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.